Introduction
Members of the myc gene family encode transcription factors which play integral roles in the control of cell growth and dierentiation, and which have been implicated strongly in the pathogenesis of several human malignancies, N-, c-, and L-myc are independently conserved and display unique tissue-speci®c expression patterns, implying that they serve distinct functions in cell proliferation and dierentiation (reviewed by Alt et al., 1986; Zimmerman et al., 1986) . In contrast to c-myc, which is widely expressed in both fetal and adult tissues, N-myc is expressed in epithelial cells early in development and only in pre-B cells later in life Grady et al., 1987; Jakobvits et al., 1985; Mugrauer et al., 1988; Xu et al., 1991; Zimmerman et al., 1986) . N-myc overexpression is observed in a subset of malignancies of neuroectodermal origin, including neuroblastoma, small-cell lung cancer, and retinoblastoma (Bartram et al., 1987; Lee et al., 1984; Nau et al., 1986; Schwab et al., 1983) . Increased expression in tumors is usually due to gene ampli®cation, and N-myc ampli®cation remains the major negative prognostic feature in neuroblastoma (Brodeur et al., 1984; Seeger et al., 1985; Slavc et al., 1990) .
Autoregulation, silencing of myc expression in the presence of high levels of Myc protein, has been demonstrated in both murine and human cell culture models, as well as in transgenic mice (Adams et al., 1986; Grignani et al., 1990; Lombardi et al., 1987) . Constitutive expression of c-myc, as a result of chromosomal translocation or under the control of a heterologous promoter, causes a reversible, dosedependent decrease in transcription from the normal allele (Hay et al., 1987; Leder et al., 1983; ar-Rushdi et al., 1983) . Autoregulation of myc family members appears to occur through a common pathway, as overexpression of N-myc in transfected cells or transgenic mice similarly down-regulates c-myc transcription (Dildrop et al., 1989; Ma et al., 1991; Rosenbaum et al., 1989; Wang et al., 1992) . Transcriptional silencing does not require continued protein synthesis, implicating the participation of a stable intermediate (Grignani et al., 1990; Lombardi et al., 1987; Penn et al., 1990) .
Investigation of the sequence elements and transacting regulators controlling N-myc expression is critical to understanding its role in both normal and aberrant growth. Speci®cally, we questioned why the markedly elevated N-Myc protein observed in ampli®ed tumors fails to silence transcription. We reasoned that autoregulation might be lost in neuroblastoma by one of three mechanisms. First, ampli®cation might result in mutation, in at least a subset of amplicons, of the cis-acting target of autoregulation. Second, ampli®cation might cause functional dilution of a trans-acting factor which mediates autoregulation by increasing the number of target sequences above a critical threshold. Lastly, autoregulation might be abolished by the functional disruption of a transacting autoregulatory intermediate. To distinguish among these possibilities, we assayed the activities of a series of human N-myc promoter-chloramphenicolacetyltransferase (CAT) reporter constructs in singlecopy and ampli®ed neuroblastoma lines. We show that autosuppression is inoperative in ampli®ed neuroblastoma cells, but that the feedback loop remains intact in single-copy lines. Loss of myc autoregulation is therefore not a property common to all transformed lines as suggested by others (Grignani et al., 1990) we have localized a cis-acting domain required for N-myc autoregulation to a minimal promoter region near the transcription initiation sites of the human N-myc gene. Our data support a model in which autoregulation depends on the activity of a trans-acting factor which is lost or functionally disabled in N-myc-ampli®ed neuroblastoma tumors.
Results
No signi®cant dierence in promoter activity is observed between single-copy and ampli®ed neuroblastoma cell lines To broadly characterize the N-myc promoter, we transiently transfected a series of human N-myc promoter-CAT reporter constructs (Figure 1 ) into a panel of human neuroblastoma and N-myc nonexpressing cell lines. We ®rst investigated whether sequences 5' to N-myc exon 1 demonstrate promoter activity and autoregulation as assayed by a linked CAT reporter gene. Signi®cant promoter activity is contained within a 2023 bp 5' EcoRI/BamHI fragment of the human N-myc gene (Table 1) . Promoter activity of this fragment is comparable to that of the SV40 promoter in our assays (Figure 2 and data not shown). Transfection of the 843 bp 5' SacII/BamHI fragment, pSII/B N-myc CAT, resulted in a consistent diminution in promoter activity, relative to that of pE/B N-myc CAT, in all cell lines tested (P50.05, two-way analysis of variance using Student-Newman-Keuls adjustment). This ®nding implies that a positive regulatory element(s) may be located between positions 7680 and 71871.
Promoter activity conferred by these 5' constructs is not cell-type-speci®c. We observed comparably high activity in the human cell lines HL-60 and HeLa, which do not express N-myc. As reported by others, expression of the larger pE/E N-myc CAT construct, which includes all of exon 1 and extends into intron 1, was seen only in lines which express endogenous Nmyc, suggesting that a tissue-speci®c regulatory element lies between nt +151 and +1058 (Table 1) (Hiller et al., 1991; Wada et al., 1992; Woodru et al., 1995) . We observed signi®cant reporter activity in ampli®ed cell lines, and in contrast to published ®ndings by Wada and colleagues (Wada et al., 1992; Woodru et al., 1995) , we saw no signi®cant decrease in the activity of our transfected N-myc promoter in single-copy relative to ampli®ed lines (Table 1) .
The myc autoregulatory circuit is maintained in singlecopy neuroblastoma cell lines Suppression of the N-myc promoter is not observed in ampli®ed neuroblastoma cell lines in tumors, in which high levels of N-Myc protein fail to suppress N-myc transcription. These results suggest that autoregulation is disrupted in these cells, or that the N-myc promoter constructs evaluated lack critical cis autoregulatory elements. Promoter activity was also observed in singlecopy lines. In single-copy lines the autoregulatory circuit might be preserved, however, yet the amount of N-Myc protein may be insucient to trigger distal eectors in the pathway. To test these possibilities, we Promoter activity from pE/B N-myc CAT could be suppressed to a similar degree in three single-copy lines by cotransfection with pSV40-human c-myc. As expected, promoter activity was not decreased in four ampli®ed lines with high endogenous N-Myc levels ( Figure 2 ). The eect observed in single-copy lines is not due to nonspeci®c promoter competition, since no suppression of pSV40-CAT or pSV40-bgal by Myc is observed (Figure 2) . Importantly, these ®ndings also show that cis-acting targets of the autoregulatory loop are contained in the 5'N-myc promoter region.
To demonstrate N-myc autoregulation directly, we cotransfected expression plasmids containing human or murine N-myc under control of the CMV promoter. Both were equally eective at down-regulating the transfected N-myc promoter in the single-copy line SK-N-SH, but had no eect on the N-myc promoter in the ampli®ed line NLF (Figure 3 ). Because both c-and Nmyc can down-regulate the N-myc promoter, these data lend further support to a model in which components of the autoregulatory pathway are shared among myc family members.
In addition to decreasing expression from transfected reporters, elevated Myc protein would be expected to diminish endogenous N-myc transcript levels if an autoregulatory pathway were intact. We measured c-myc RNA derived from the transfected expression vector pSPc-myc and endogenous N-myc RNA levels in transfected cells by slot-blot analysis. A cis-acting element required for cross-regulation by cMyc maps near the transcription initiation sites
To localize more precisely cis-acting elements mediating autoregulation by Myc, we generated a series of CAT reporter constructs with sequential 5' deletions extending from the SacII site in pSII/B N-myc CAT. Promoter activity of this construct is down-regulated to a similar extent as that of pE/B N-myc CAT by overexpression of exogenous c-Myc (data not shown). We reasoned that as the element(s) necessary for crossregulation were deleted, the activity of the transfected promoter would become unresponsive to cotransfected c-myc. In agreement with published results (Wada et al., 1992; Woodru et al., 1995) , promoter activity decreases substantially as progressive 5' deletions are made, suggesting that a number of positive regulatory factors bind in this region of the N-myc promoter ( Figure 5 ). The 7233 deletion construct, however, is still subject to cross-regulation by c-Myc despite a low basal activity. The +105 construct, in contrast, shows negligible reporter activity, which is not detectably aected by exogenous c-Myc expression. This construct lacks most of the initiation sites previously mapped for the human N-myc gene. The pattern of responsiveness to c-Myc overexpression is similar in the single-copy lines LHN and SK-N-SH (data not shown).
As observed in previous experiments, promoter activity of the larger pE/B N-myc CAT reporter was similar in ampli®ed and single copy lines (Figures 2  and 5 ). Interestingly, some 5' deletions showed signi®cantly greater activity in the ampli®ed line NGP than in the single copy line LHN, suggesting that ampli®ed neuroblastoma cells may overproduce positive regulators which bind these regions of the promoter. Importantly, however, promoter activity of any reporter was not diminished by c-Myc in the ampli®ed line, NGP ( Figure 5 ). Thus, a cis-acting region necessary for autosuppression by Myc maps near N-myc transcription initation sites.
Myc suppression of the Adenovirus major late promoter and autosuppression involve distinct pathways
One potential mechanism by which Myc proteins might mediate autosuppression is by interfering with the assembly of the preinitiation complex at core promoter elements of myc genes. c-Myc protein has recently been reported to suppress transcription from several promoters, and repression appears to require intact initiator (Inr) sites (Javahery et al., 1994; Li et al., 1994; Mai and Martensson, 1995; Philipp et al., 1994; Solomon et al., 1995; Yang et al., 1993) . Recently, Facchini and colleagues have shown that the c-Myc domains required for suppression of the AdMLP coincide with those required for autosuppression but dier from those domains necessary for Myc suppression of the cyclin D1 promoter (Facchini et al., 1997; Penn et al., 1990; Philipp et al., 1994) . To test directly whether the components necessary for myc autoregulation participate in Myc down-regulation of the AdMLP, we cotransfected Myc expression plasmids with pAdMLP-CAT or with a construct containing a mutated Inr site, pAdDInr-CAT (kind gift of Dr Chi Dang, Johns Hopkins University, Baltimore, MD) into If pathways involved in myc autoregulation are shared with Myc-mediated suppression of the AdMLP, N-Myc should be capable of suppressing expression from AdMLP in autoregulation-competent single-copy neuroblastoma lines, but not in ampli®ed lines. Suppression would be abolished by mutation of the AdMLP Inr. The transfected AdMLP was active in murine ®broblasts and, as demonstrated previously, was down-regulated by human c-myc in a dosedependent manner (Figure 6a ) (Lee et al., 1996) . We further show that N-myc can suppress the AdMLP to a similar extent in this cell line. As reported for c-Myc, N-Myc repression of the AdMLP requires an intact Inr element (Figure 6a vs d) . In contrast, the activity of the AdMLP was not decreased by overexpression of exogenous Myc in either ampli®ed or autoregulationcompetent single-copy neuroblastoma lines, even at levels of plasmid DNA which gave maximal repression in L929 cells (Figure 6b and c) . Promoter activity of the AdMLPDInr construct was lower than that of the parent construct in all cell lines tested. These results suggest that distinct pathways exist for repression between the AdMLP and c-or N-myc promoters, but do not rule out the possibility that a common factor shows dierent anities for site(s) within these promoters.
Discussion
In the present studies, we investigated whether the myc autoregulatory circuit is functional in human neuro- blastoma. We analyzed the activity of the N-myc promoter as a function of N-myc gene copy number by transfecting a series of N-myc promoter-CAT reporter constructs into a panel of human neuroblastoma lines carrying one or multiple copies of the endogenous Nmyc gene. Signi®cant promoter activity was observed in ampli®ed lines containing high levels of N-Myc protein, indicating that the normal autoregulatory circuit is disrupted in these lines. All four single-copy lines tested synthesize insucient N-Myc protein to trigger requisite distal eector(s), but both the transfected N-myc promoter and the endogenous Nmyc gene can be down-regulated by overexpression of exogenous c-or N-Myc. These results imply that the observed eects on transfected plasmids parallel those on the endogenous promoter.
Our results showing loss of myc autoregulation in ampli®ed neuroblastoma are in agreement with studies reported from other laboratories. Breit and Schwab demonstrated down-regulation of c-myc expression in the single-copy neuroblastoma line, SK-N-SH, in the presence of increased N-Myc protein levels from a transfected expression vector (Breit and Schwab, 1989 ). Grignani showed loss of myc autoregulation in the ampli®ed line SK-N-MC (Grignani et al., 1990) . Thus, in a total of eight lines examined to date, three singlecopy and ®ve N-myc ampli®ed, there is a strict correlation between N-myc ampli®cation and loss of the normal autoregulatory circuit.
We initially reasoned that loss of autoregulation could occur by one of three mechanisms. First, ampli®cation may result in mutation or loss of cisacting sequences which mediate autoregulation, rendering a subset of ampli®ed domains unresponsive to transcriptional silencing. If this mechanism were operative, we would expect our promoter constructs to be down-regulated in amplifed cell lines, provided that they carry the requisite cis-acting target sequences. This possibility is excluded, since we observed high promoter activity in both ampli®ed and single-copy neuroblastoma cell lines.
A second model to explain loss of autoregulation invokes the functional dilution of a trans-acting autoregulatory factor by ampli®cation of its target (Bertling et al., 1987) . Our ability to down-regulate N-myc promoter activity from this number of copies (1000-fold over the number of endogenous promoters present in ampli®ed cells in vivo) indicates that a large quantity of transfected plasmid DNA does not functionally dilute a transacting autoregulatory factor. By extension, the presence of hundreds of promoter domains in ampli®ed tumors cannot be solely responsible for the absence of autoregulation in these cells.
A third potential mechanism leading to the absence of autoregulation is loss or mutation of a trans-acting factor which mediates the process. Our data are consistent with this model. The loss of a trans-acting myc autoregulatory factor in ampli®ed tumors is supported by a number of previous studies as well. In cell fusion experiments by Versteeg and colleagues, hybrids between a ®broblast line and the N-myc ampli®ed neuroblastoma line IMR-32 demonstrated silencing of N-myc expression, presumably due to provision of a trans-acting factor in the ®broblasts capable of maintaining homeostatic myc levels despite increased gene copy number (Versteeg et al., 1990) .
While the work of Grignani and colleagues has suggested that c-myc autoregulation is lost in most transformed cell lines (Grignani et al., 1990) , our results document that N-myc autoregulation is in fact preserved in single-copy neuroblastoma lines. Loss of autoregulation is therefore not a property common to all tumors, and it may represent a later event in malignant progression, possibly associated with gene ampli®cation. Interestingly, no single-copy tumors or cell lines have been reported to lack autoregulation. Nmyc ampli®cation would not be expected to lead to increased expression and a consequent growth advantage to cells in which autoregulation were preserved, since it would not lead to increased Myc protein. Tlsty and coworkers demonstrated that gene ampli®cation segregates as a recessive trait in somatic cell hybrids , consistent with the loss of a tumor suppressor prior to ampli®cation. Indeed, functional disruption of both p53 alleles is associated with altered cell-cycle arrest and with gene ampli®cation (Livingstone et al., 1992; Yin et al., 1992) . Numerous studies have, however, documented a low frequency of p53 mutations in neuroblastoma (Goldman et al., 1996; Vogan et al., 1993) . Some tumors with wild-type p53 do have the potential to amplify endogenous genes under speci®c selective pressures, indicating that alternative pathways for ampli®cation exist (Livingstone et al., 1992) . Loss of chromosome region 1p36, the location of a putative tumor suppressor gene in neuroblastoma, correlates strongly with N-myc ampli®cation (Brodeur et al., 1984) .
The precise mechanism of myc autoregulation is unde®ned, but a number of models can be considered which incorporate the data presented. Myc-Max heterodimers are known to modulate the transcription of downstream targets through E-box (CACGTG) elements (Blackwood and Eisenman, 1991; Blackwood et al., 1992) . The N-myc promoter does not contain an E-box, and E-box elements characterized to date activate transcription, making direct transcriptional repression by Myc-Max an unlikely mechanism for myc autoregulation (Eilers et al., 1991; Gaubatz et al., 1994 Gaubatz et al., , 1995 Li et al., 1994; Wagner et al., 1993; Penn et al., 1990a) . In addition, Buckle and Mechali provided additional evidence that c-myc autosuppression occurs through an indirect circuit by demonstrating lack of Myc:Max binding to Xenopus c-myc genomic DNA (Buckle and Mechali, 1995) . It is formally possible that Myc-Max may activate transcription of a myc repressor through an E-box. The requirement for the leucine zipper domain of Myc and more recent experiments showing an obligatory role for Max in autoregulation are consistent with this potential mechanism (Crouch et al., 1990; Facchini et al., 1997) .
Although much experimental attention has focused on Myc's role as a transcriptional activator, recent ®ndings also underscore its importance as a transcriptional repressor. c-Myc has recently been reported to suppress transcription from several promoters including the adenovirus major late promoter (AdMLP) and the cyclin D1, c/EBPa, l5, albumin and terminal deoxynucleotidyl transferase (TdT) promoters. Repression of these promoters appears to require intact initiator (Inr) sites (Li et al., 1994; Mai and Martensson, 1995; Philipp et al., 1994; Roy et al., 1993; Solomon et al., 1995; Yang et al., 1993) . Mycdependent transcriptional repression at a`consensus' Inr sequence has been demonstrated in vitro (Lee et al., 1996) . Myc can associate with TATA-binding protein (TBP) and could thereby interfere with formation of a competent preinitiation complex at core promoter elements (Maheswaran et al., 1994) . Myc has also been shown to repress transcription by the activators Yin-Yang-1 (YY1) and TFII-I, both of which can bind to Inr elements (Roy et al., 1993; Shrivastava et al., 1993) .
c-Myc protein domains essential for autoregulation include N-terminal amino acids 106 ± 143 and Cterminal amino acids 354 ± 433 (Penn et al., 1990b; Facchini et al., 1997) . These regions are also essential for suppression of the AdMLP, but dier from those domains involved in suppression of the cyclin D1 promoter (Li et al., 1994; Philipp et al., 1994) . On the basis of these observations, we speculated that repression mechanisms may be shared between the AdMLP and the c-myc promoter. Our studies show that although both c-and N-myc are capable of suppressing AdMLP in murine ®broblasts, neither can suppress the AdMLP in neuroblastoma cells. These results suggest the participation of distinct components in transcriptional repression by Myc at these two promoters. Despite evidence that Myc may bind to TBP and TFII-B in vitro (Maheswaran et al., 1994) , our results argue against disruption of the preintiation complex by direct association of a repressor with general transcription factors, since these factors would presumably be present at both the AdMLP and the myc promoters.
Our results and previous studies provide additional support for a common autoregulatory mechanism controlling expression of myc family members, implying that shared autoregulatory target sequences are located within the two promoters. The two promoters lack signi®cant sequence homology, however, and are controlled through distinct transcriptional regulatory mechanisms. c-and N-myc display distinct spatial and temporal expression patterns. Most c-myc transcripts initiate from one of two discrete promoters, P1 and P2, each of which is preceded by a TATA box (Nepveu et al., 1987; Bentley and Groudine, 1986) . N-myc transcripts, in contrast, initiate from heterogeneous sites 5' to and within exon 1 Stanton and Bishop, 1986; Wada et al., 1992) . Facchini and colleagues have recently shown that c-myc autosuppression can be mediated by minimal P2 promoter sequences (Facchini et al., 1997) . Our results indicate similarly that cis-acting targets of autoregulation are present within a minimal N-myc promoter. the N-and c-myc promoters do share E2 and Inr elements. Mutation of either the E2 or Inr site in the c-myc promoter, however, failed to abrogate autosuppression (Facchini et al., 1997) . Thus, despite distinct transcriptional regulatory mechanisms and lack of sequence homology both promoters are autoregulated. It is therefore possible that a trans-acting repressor may interfere with the assembly of general transcription factors at a core promoter element (shared by all promoters, either TATA or Inr elements). Our data show that the AdMLP is not repressed by Myc in autoregulation-competent single-copy neuroblastoma cells, further arguing against a direct interaction of a repressor with the basal transcription machinery. Our data are more consistent with a model in which a repressor may contact the preinitiation complex through an accessory protein active at the myc promoter.
In the present studies, we assessed autoregulation in human neuroblastoma using transient transfection of a series of promoter-deletion minigenes. We determined that autoregulation is lost in ampli®ed neuroblastoma cell lines, but remains intact in single-copy cells. A cisacting element required for this down-regulation is located within 233 bp upstream from the transcription initiation sites. N-myc autoregulation may involve the direct activation of a downstream repressor, sequestration of an activator, or direct N-Myc interaction with component(s) of the initiation complex. Future studies are aimed at dissection of these potential mechanisms and identi®cation of the direct regulators involved in myc autoregulation.
Methods

N-myc gene isolation and construction of reporter plasmids
N-myc genomic DNA clones were isolated from a human ®broblast library (gift of Dr Stanley Korsmeyer, Washington University, St. Louis, MO) using the exon 2-speci®c probe pNb-1 generously provided by Dr J Michael Bishop, University of California, San Francisco (Stanton et al., 1986) . Five phage clones were initially plaque-puri®ed. One clone containing the entire N-myc gene was digested with EcoRI yielding three fragments, each containing one of the three exons. The 5' portion of exon 1 was sequenced by the dideoxy termination technique (Sambrook et al., 1989) .
Constructs corresponding to (a) a 2023 bp EcoRI/BamHI fragment from the 5' untranslated region of human N-myc (pE/B N-myc CAT, (b) an 843 bp 5' fragment obtained from SacII cleavage of pE/B (pSII/B N-myc CAT), and (c) a 2821 bp EcoRI/EcoRI fragment spanning exon 1 and extending into intron 1 (pE/E N-myc CAT), were obtained by appropriate restriction digestion (Figure 1) (Putney et al., 1981) . Individual clones were sequenced by the dideoxy termination technique to determine the precise locations of deletions.
The pN-myc luciferase reporter plasmid was generated by ligation of an 1848 bp SacI/BamHI 5' N-myc fragment (Figure 1) into the pGL3 Basic vector (Promega). N-myc expression plasmids were constructed by ligation of EcoRIdigested human or murine N-myc cDNAs (kindly provided by Dr Averil Ma, Children's Hospital, Boston, MA) into pcDNA3 (Invitrogen, San Diego, CA).
Cell culture and transfections
HL-60, HeLa and the neuroblastoma lines SK-N-SH, NBL-S, LHN, IMR-32, NGP, and NMB were maintained in RPMI 1640 (Gibco) supplemented with 10% fetal calf serum (Hyclone, Logan, UT). Cells were transiently transfected using published electroporation techniques (Chu et al., 1987) or liposome-mediated transfection according to the manufacturer's recommendations (Lipofectamine R , Gibco). Cells at 50 ± 80% con¯uence were split and supplemented with fresh medium 24 h prior to transfection. All samples were cotransfected with pSV40-b-galactosidase to control for variable transfection eciency among cell lines.
To determine whether single-copy neuroblastoma lines produce insucient N-Myc protein to initiate the autoregulatory pathway, an expanded panel of lines were cotransfected with N-myc promoter-CAT reporter constructs and either a c-myc expression vector, pSPc-myc (gift of Dr Robert Eisenman, Fred Hutchinson Cancer Research Center, Seattle, WA), or a murine or human N-myc expression vector. In all myc cotransfection experiments, pSV40-CAT or pcDNA3 (CMV promoter) plasmid DNA was added to control transfections so that all samples were incubated with an equal amount of promoter-competent plasmid DNA.
Assays of b-galactosidase (b-gal),chloramphenicol acetyltransferase (CAT), and luciferase activities For CAT assays, cells were harvested 48 h after transfection, and 5610 6 viable cells from each sample, determined by trypan blue exclusion, were resuspended in 100 ml 0.25 M Tris HCl [pH 8.0] and crude extracts obtained by three rapid freeze-thaw cycles. Membrane debris was cleared by centrifugation, and extracts assayed immediately or stored for up to 2 weeks at 7808C.
b-gal assays were performed spectrophotometrically or by chemiluminescence using the GalactoLight R reagent kit (Tropix, Bedford, MA) in parallel with serial dilutions of puri®ed enzyme (Promega) (An et al., 1982) . Assays of CAT were performed by phase extraction (Seed and Sheen, 1988) in parallel with serial dilutions of commercial enzyme (Promega). Samples were heated to 658C for 10 min to inactivate endogenous deacetylase activity. Following a 4 h incubation at 378C, organic extraction was performed using 300 ml mixed xylenes (Aldrich). Counts in the organic (butyrylated chloramphenicol), aqueous (native chloramphenicol), and total samples were determined by scintillation counting, and CAT activity of each sample was normalized to its b-gal activity to control for variable transfection eciency.
Cell extracts for luciferase and parallel b-gal assays were prepared in commercial lysis buer according to the manufacturer's protocol (Promega). Luciferase assays were performed in 96-well microtiter plates using an automated luminometer and commercial reagents according to the manufacturer's recommendations (Promega). Time-course experiments demonstrated that samples were assayed in the linear ranges for enzyme activities (data not shown).
RNA extraction and slot-blot analysis
To determine the eect of Myc overexpression on endogenous N-myc RNA levels, RNA slot blot analysis was performed on cells transiently transfected with the cmyc expression vector, pSPc-Myc, which contains the human c-myc cDNA driven by the SV40 promoter. RNA was harvested from transfected cells using Trizol R (Gibco) according to the manufacturer's protocol. Two mg of RNA from each sample was applied to Duralon-UV membranes (Stratagene) by vacuum ®ltration (BioDot apparatus, BioRad). Membranes were u.v. cross-linked and hybridized to probes speci®c for human b-actin, N-, and c-myc labeled by the random hexamer method (Prime-It R , Stratagene). Probes used were a 2.0 kb human b-actin cDNA, a 1.8 kb c-myc cDNA (gift of Dr Robert Eisenman), and a 301 bp BamHI-Bg1II fragment of Nmyc exon 1. Following hybridization (16 h, 428C) ®lters were washed twice in 26SSC, 0.1% SDS at room temperature for 15 min, then twice in 0.16SSC, 0.1% SDS at 658 for 15 min. Filters were then exposed to X-ray ®lm (Hyper®lm, Kodak) for 2 ± 10 days. Quantitation of autoradiographic signals was performed on a Series 300 scanning densitometer using ImageQuant 3.2 software (Molecular Dynamics, Sunnyvale, CA).
Statistical analysis
Statistical analysis was performed using the Statistical Analysis System (SAS, SAS Institute Inc. SAS/STAT User's Guide, Version 6, Fourth Edition. Cary, NC, 1989) .
